Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04266886 · ClinicalTrials.gov registry record · NA

Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer

A NA study of Malignant Female Reproductive System Neoplasm and Metastatic Cervical Cancer, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
152
Enrollment target
1
Study location

NCT04266886 is a NA study of Malignant Female Reproductive System Neoplasm and Metastatic Cervical Cancer that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 152 participants, below the 396-participant average among 18 other Malignant Female Reproductive System Neoplasm trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04266886, a NA study of Malignant Female Reproductive System Neoplasm and Metastatic Cervical Cancer, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
152 participants
Enrollment target
1
Study location

Study Summary

This trial studies how well self-hypnosis works in enhancing recovery after surgery in patients with gynecologic cancer. A guided relaxation method called self-hypnosis may help affect how patients feel pain and symptoms after surgery.

Interventions

  • OTHER Quality-of-Life Assessment
  • OTHER Questionnaire Administration
  • OTHER Best Practice
  • PROCEDURE Hypnotherapy

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 152 participants
Start Date 2018-09-11
Est. Completion 2027-12-31
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT04266886

The ClinicalTrials.gov registry entry for NCT04266886 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 396-participant average among 18 other Malignant Female Reproductive System Neoplasm trials with a reported enrollment target (62% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Malignant Female Reproductive System Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.

NCT04266886 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT04266886 about?

NCT04266886 is a clinical study titled "Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer". This trial studies how well self-hypnosis works in enhancing recovery after surgery in patients with gynecologic cancer. A guided relaxation method called self-hypnosis may help affect how patients feel pain and symptoms after surgery.

What is the current status of trial NCT04266886?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 152 participants. The study started on 2018-09-11. Estimated completion is 2027-12-31.

What conditions does trial NCT04266886 study?

This clinical trial studies the following conditions: Malignant Female Reproductive System Neoplasm, Metastatic Cervical Cancer, Recurrent Malignant Female Reproductive System Neoplasm.

What interventions are being tested in trial NCT04266886?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Best Practice (OTHER), Hypnotherapy (PROCEDURE).

Who is sponsoring clinical trial NCT04266886?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04266886 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Female Reproductive System Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.